Study on the correlation between serum asprosin and insulin in non-pregnant adult patients

Study on the relationship between asprosin and type 2 diabetes mellitus and its use as a new target for the treatment of type 2 diabetes mellitus

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900027876

Enrollment

Unknown

Registered

2019-12-01

Start date

2019-12-01

Completion date

Unknown

Last updated

2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

OGTT Insulin >100uIU/ml group:N/A

OGTT Insulin<100uIU/ml group:N/A

Eligibility

Sex/Gender

All

Age

15 Years to 75 Years

Inclusion criteria

Inclusion criteria: Insulin elevation group: 1. Patients undergoing ogtt test in the first affiliated Hospital of Nanhua University. 2. Aged 18 to 75 years, sex unlimited; 3. According to the South China Endocrine Laboratory Standard, any time point of ogtt: insulin > 100uIU / ml; 4. Those who volunteered to participate in this study and signed informed consent. Control group: 1. Patients undergoing ogtt test in the first affiliated Hospital of Nanhua University. 2. Aged 18 to 75 years, regardless of sex; 3. According to the South China Endocrine Laboratory Standard, ogtt is satisfied at any time point: insulin < 100uu / ml; 4. Those who volunteered to participate in this study and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. During pregnancy or lactation; 2. Those who used glucocorticoids for nearly 3 months or were in the process of using glucocorticoids.

Design outcomes

Primary

Measure	Time frame
asprosin;Insulin;	—

Countries

China

Contacts

Public ContactTao Hong

The First Affiliated Hospital of South China University

15807349280@163.COM+86 15807349280

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026